Ingevity (NGVT) Liabilities and Shareholders Equity (2015 - 2026)

Ingevity (NGVT) has 12 years of Liabilities and Shareholders Equity data on file, last reported at $1.7 billion in Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $1.7 billion, down 19.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.0 billion (down 18.14% YoY), and the FY2025 annual result was $1.7 billion, down 18.37% from the prior year.
• Liabilities and Shareholders Equity was little changed at $1.7 billion in Q1 2026 per NGVT's latest filing, from $1.7 billion in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $2.8 billion in Q2 2023 and troughed at $1.7 billion in Q1 2026.
• A 5-year average of $2.3 billion and a median of $2.3 billion in 2022 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2023 and 2024: Liabilities and Shareholders Equity increased 19.54% in 2023, then retreated 22.9% in 2024.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $2.7 billion in 2022, then dropped by 4.14% to $2.6 billion in 2023, then dropped by 22.9% to $2.0 billion in 2024, then fell by 18.37% to $1.7 billion in 2025, then declined by 0.05% to $1.7 billion in 2026.
• Business Quant data shows NGVT's Liabilities and Shareholders Equity at $1.7 billion in Q1 2026, $1.7 billion in Q4 2025, and $1.8 billion in Q3 2025.